[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
From the Centers for Disease Control and Prevention
November 22/29, 2000

CDC Contract for Additional 9 Million Doses of Influenza Vaccine for the 2000-01 Season

JAMA. 2000;284(20):2586. doi:10.1001/jama.284.20.2586

MMWR. 2000;49:999

CDC has contracted with Aventis-Pasteur, Inc. (Av-P) for the production of 9 million doses of influenza vaccine for the 2000-01 season. This additional production ensures that approximately the same quantity of influenza vaccine is available for the 2000-01 season as the previous year.1,2 The 9 million doses are not intended to substitute for vaccine that is already ordered and expected to be delivered.

For the 1999-2000 influenza season, approximately 77 million doses of influenza vaccine were distributed in the United States, of which 3 million doses were returned to the manufacturers. For the 2000-2001 influenza season, distribution of approximately 75 million doses is anticipated, including the 9 million doses contracted by CDC.

Av-P will give first priority to orders from providers who plan to vaccinate primarily high-risk persons. Applications for vaccine orders from health-care providers and programs should be sent directly to Av-P beginning November 3, 2000. Wholesale distributors can apply to purchase vaccine starting December 4, 2000, if doses remain available. Once an application has been received by Av-P, notification regarding order acceptance will be provided to the applicant before mid-December. Delivery of vaccine is anticipated to begin December 12, 2000, and end by early January 2001.

Additional information about the application process and vaccine availability is available through Av-P, telephone (800) 720-8972, or World-Wide Web, http://www.vaccineshoppe.com (click on Fluzone (Registered) Application Form link). Completed application forms can be faxed to (888) 889-7129. Orders for this vaccine will not be taken by telephone.

CDC's National Immunization Program (NIP) has developed an "Influenza Vaccine Availability" website that will provide information about the availability of influenza vaccine from manufacturers and wholesale distributors and will list state health departments that may have information about vaccine availability among local providers. This website will be updated weekly. The website can be accessed at http://www.cdc.gov/nip/flu-vac-supply. The updated ACIP recommendations for influenza vaccine for the 2000-01 season and other influenza-related information can be accessed at http://www.cdc.gov/ncidod/diseases/flu/fluvirus.htm. Additional information and assistance can be obtained by contacting NIP by e-mail, nipinfo@cdc.gov, or by telephone, (800) 232-2522.

References
1.
CDC, Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season. MMWR. 2000;49888- 92
2.
CDC, Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. MMWR. 2000;49619- 22
×